相关实验视频
Updated: Jul 19, 2026

07:35
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
预测希佩尔-林道氏病相关恶性瘤进展的因素:一个纵向队列研究
Jae Ho Lee1, Hyun Young Lee2, Ji Eun Park3
1Department of Radiology and Center for Imaging Science, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
BMC cancer
|March 29, 2025
概括
希佩尔-林道 (VHL) 疾病的进展与遗传亚型无关. 较大的瘤和男性预测VHL患者的血管母细胞瘤和细胞癌进展.
科学领域:
- 遗传学 遗传学是一种遗传学.
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 希佩尔-林多 (VHL) 疾病呈现出多种不同的遗传亚型,进展不清楚.
- 通过基因组亚型来表征VHL疾病的进展对于管理至关重要.
研究的目的:
- 根据基因组亚型分析VHL疾病的随访持续时间,治疗率和进展模式.
- 为了确定VHL疾病进展的风险因素.
主要方法:
- 追溯分析94名患有VHL疾病的患者 (2003年6月至2020年6月).
- 使用MRI和CT数据,比较误解和截断VHL基因突变之间的瘤发病率.
- 考克斯回归分析以确定血管母细胞瘤 (Hb) 和细胞癌 (RCC) 进展的预测因子.
主要成果:
- 误解突变与与切断突变相比,对RCC和上腺染细胞瘤的治疗率更高相关.
- 遗传亚型没有显著预测Hb或RCC.的进展时间.
- 基线瘤体积增加独立预测Hb和RCC进展.
- 男性性别独立地预测了RCC进展.
结论:
- VHL疾病的进展与遗传亚型无关.
- 在VHL疾病中的Missense突变与RCC和上腺染细胞瘤的治疗需求增加相关.
- 基线瘤体积和男性性别是管理VHL疾病中Hb和RCC进展的关键预测因素.
相关概念视频
Longitudinal Research
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

